Raymond James & Associates Spdr Ser Tr Spdr S&P Biotech E Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Raymond James & Associates holds 383,355 shares of XBI stock, worth $35 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
383,355
Previous 355,844
7.73%
Holding current value
$35 Million
Previous $33 Million
14.81%
% of portfolio
0.02%
Previous 0.02%
Shares
30 transactions
Others Institutions Holding XBI
# of Institutions
927Shares Held
101MCall Options Held
28.4MPut Options Held
33.4M-
Goldman Sachs Group Inc New York, NY12.7MShares$1.16 Billion0.21% of portfolio
-
Jpmorgan Chase & CO New York, NY12.3MShares$1.12 Billion0.1% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A69.23MShares$842 Million2.24% of portfolio
-
Morgan Stanley New York, NY8.02MShares$732 Million0.06% of portfolio
-
Citigroup Inc7.75MShares$707 Million0.45% of portfolio